The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Hodgkin Disease

This is a "connection" page, showing publications Kenneth S. Cohen has written about Hodgkin Disease.
Connection Strength

0.187
  1. Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 07 01; 107(7):1608-1618.
    View in: PubMed
    Score: 0.187
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.